• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

热灌注术中胸腹联合化疗治疗IVB期上皮性卵巢癌

Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma.

作者信息

Brind'Amour Alexandre, Tremblay Elizabeth, Fortin Suzanne, De Guerke Lara, Auclair Marie-Hélène, Dubé Pierre, Sidéris Lucas

机构信息

Division of Surgical Oncology, Maisonneuve-Rosemont Hospital, Montreal, Canada.

Department of Obstetrics and Gynecology, University of Montreal, Montreal, Canada.

出版信息

Gynecol Oncol Rep. 2020 Oct 2;34:100654. doi: 10.1016/j.gore.2020.100654. eCollection 2020 Nov.

DOI:10.1016/j.gore.2020.100654
PMID:33102673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7569208/
Abstract

•Full-thickness diaphragmatic infiltration with pleural effusion in advanced epithelial ovarian cancer is challenging.•Short-term control of malignant pleural effusion with HITAC for advanced epithelial ovarian cancer seems feasible.•Carboplatin is safe when used as HIPEC or HITAC agent for advanced epithelial ovarian cancer.

摘要

•晚期上皮性卵巢癌全层膈肌浸润伴胸腔积液具有挑战性。

•用热隔离腹腔化疗（HITAC）短期控制晚期上皮性卵巢癌的恶性胸腔积液似乎可行。

•顺铂用作晚期上皮性卵巢癌的腹腔热灌注化疗（HIPEC）或热隔离腹腔化疗（HITAC）药物时是安全的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/1e7dede18ffa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/d47517832c97/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/ae19ca7f4c14/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/1e7dede18ffa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/d47517832c97/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/ae19ca7f4c14/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb2/7569208/1e7dede18ffa/gr3.jpg

相似文献

1
Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma.热灌注术中胸腹联合化疗治疗IVB期上皮性卵巢癌
Gynecol Oncol Rep. 2020 Oct 2;34:100654. doi: 10.1016/j.gore.2020.100654. eCollection 2020 Nov.
2
Hyperthermic intraoperative thoracoabdominal chemotherapy.高热术中胸腹化疗。
Gastroenterol Res Pract. 2012;2012:623417. doi: 10.1155/2012/623417. Epub 2012 May 10.
3
Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer.卵巢癌、输卵管癌和原发性腹膜癌行细胞减灭术和卡铂腹腔热灌注化疗后的发病率。
J Surg Oncol. 2019 Sep;120(3):550-557. doi: 10.1002/jso.25603. Epub 2019 Jul 2.
4
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.减瘤手术及热灌注化疗治疗复发性卵巢癌：30天发病率和死亡率分析
Ann Surg Oncol. 2015 Feb;22(2):655-61. doi: 10.1245/s10434-014-4026-6. Epub 2014 Aug 26.
5
The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.减瘤手术及腹腔热灌注化疗（HIPEC）在卵巢癌治疗中的作用：综述
Indian J Surg Oncol. 2016 Jun;7(2):188-97. doi: 10.1007/s13193-016-0501-9. Epub 2016 Feb 16.
6
Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.原发性或继发性肿瘤细胞减灭术联合术中腹腔内热灌注化疗（HIPEC）治疗晚期上皮性卵巢癌。
Minerva Ginecol. 2017 Apr;69(2):119-127. doi: 10.23736/S0026-4784.16.03959-9. Epub 2016 Jul 14.
7
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.细胞减灭术和腹腔内热灌注化疗（HIPEC）治疗持续性和复发性晚期卵巢癌：246 例多中心前瞻性研究。
Ann Surg Oncol. 2012 Dec;19(13):4052-8. doi: 10.1245/s10434-012-2510-4. Epub 2012 Jul 24.
8
Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges.细胞减灭性肿瘤手术联合腹腔内热灌注化疗和胸腔内热化疗：围手术期挑战
Saudi J Anaesth. 2019 Apr-Jun;13(2):131-135. doi: 10.4103/sja.SJA_545_18.
9
Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study.细胞减灭术和腹腔内热灌注化疗对原发性上皮性卵巢癌复发模式的影响：基于倾向评分的病例对照研究。
J Gynecol Oncol. 2018 May;29(3):e53. doi: 10.3802/jgo.2018.29.e53. Epub 2018 Mar 12.
10
Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗时代结直肠癌和阑尾癌卵巢转移的治疗
Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28.

引用本文的文献

1
Outcomes Following Cytoreductive Surgery and Hyperthermic Intraoperative Thoraco-Abdominal Chemotherapy with Diaphragm Resection for Peritoneal Carcinomatosis: A Retrospective Cohort Study.细胞减灭术和术中高热腹腔-胸腔化疗联合膈肌切除术治疗腹膜癌转移的结果：一项回顾性队列研究。
Ann Surg Oncol. 2024 Feb;31(2):1058-1068. doi: 10.1245/s10434-023-14470-8. Epub 2023 Oct 22.

本文引用的文献

1
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.腹腔内热灌注化疗联合细胞减灭术的适应证：系统评价。
Eur J Cancer. 2020 Mar;127:76-95. doi: 10.1016/j.ejca.2019.10.034. Epub 2020 Jan 24.
2
Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer.卵巢癌、输卵管癌和原发性腹膜癌行细胞减灭术和卡铂腹腔热灌注化疗后的发病率。
J Surg Oncol. 2019 Sep;120(3):550-557. doi: 10.1002/jso.25603. Epub 2019 Jul 2.
3
Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges.
细胞减灭性肿瘤手术联合腹腔内热灌注化疗和胸腔内热化疗：围手术期挑战
Saudi J Anaesth. 2019 Apr-Jun;13(2):131-135. doi: 10.4103/sja.SJA_545_18.
4
Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei.腹膜假黏液瘤的细胞减灭术及术中热灌注胸腹联合化疗（HITAC）的围手术期管理
Indian J Anaesth. 2019 Feb;63(2):134-137. doi: 10.4103/ija.IJA_825_18.
5
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.FIGO 卵巢癌分期 IVA 与 IVB：新辅助化疗的预后价值和预测价值。
Int J Gynecol Cancer. 2018 Mar;28(3):453-458. doi: 10.1097/IGC.0000000000001186.
6
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: A systematic review and meta-analysis.胸腔内热化疗（HITHOC）对恶性胸腔积液的影响：一项系统评价和荟萃分析。
Medicine (Baltimore). 2017 Jan;96(1):e5532. doi: 10.1097/MD.0000000000005532.
7
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.ESMO-ESGO-ESTRO 子宫内膜癌共识会议：诊断、治疗和随访。
Ann Oncol. 2016 Jan;27(1):16-41. doi: 10.1093/annonc/mdv484. Epub 2015 Dec 2.
8
The impact of pleural disease on the management of advanced ovarian cancer.
Gynecol Oncol. 2015 Jul;138(1):216-20. doi: 10.1016/j.ygyno.2015.05.003. Epub 2015 May 9.
9
Hyperthermic intraoperative thoracoabdominal chemotherapy.高热术中胸腹化疗。
Gastroenterol Res Pract. 2012;2012:623417. doi: 10.1155/2012/623417. Epub 2012 May 10.
10
Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.减瘤手术联合改良热灌注化疗治疗晚期复发性卵巢癌——单中心12年经验
Eur J Surg Oncol. 2009 Nov;35(11):1186-91. doi: 10.1016/j.ejso.2009.03.004. Epub 2009 Apr 8.